Wedgewood Pharmacy (New Harbor Capital) Acquires Leiters Enterprises' San Jose 503B Assets and Wildlife Pharmaceuticals (ZooPharm)

June 17, 2020

Wedgewood Pharmacy, a portfolio company of New Harbor Capital, has reached definitive agreements to acquire the San Jose, California assets of Leiters Enterprises (a 22,000 sq ft FDA-registered 503B outsourcing facility) and to acquire Wildlife Pharmaceuticals, Inc. and its subsidiary ZooPharm. The 503B facility will operate as Wedgewood Connect and is expected to begin releasing select sterile injectables and ophthalmics in Q4 2020; both transactions are subject to closing timelines and regulatory approvals.

Buyers
Wedgewood Pharmacy, New Harbor Capital
Targets
Leiters Enterprises (San Jose 503B facility), Wildlife Pharmaceuticals, Inc. (ZooPharm)
Sellers
Leiters Enterprises, Wildlife Pharmaceuticals, Inc., ZooPharm
Platforms
Wedgewood Pharmacy
Industry
Veterinary
Location
United States
Transaction Type
Addon

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.